The State Pharmaceuticals Corporation (SPC) has contributed Rs. 1.118 billion to the Treasury in 2025 through income tax and other levies, reflecting a 173 per cent increase compared to 2024, the Ministry of Health said yesterday (15).
The Ministry noted that the SPC also recorded a 26 per cent rise in revenue from its Own Revenue Stream (ORS), while income generated through the State Osusala pharmacy network increased by 9 per cent during the year.
For the first time in its 53-year history, the SPC achieved full utilisation of its annual budget allocation for supplies to the Department of Health Services in 2025 through the issuance of indent orders. ORS production also rose by 36 per cent year-on-year.
Revenue growth from the State Osusala network was partly driven by the opening of five new outlets in Kiribathgoda, Narahenpita, Kegalle, Kalmunai and Batticaloa, along with improved operational efficiency that helped several pharmacies return to profitability.
The Ministry added that the SPC has initiated the ISO 17025 laboratory accreditation process to further strengthen drug quality and safety standards. As part of its corporate social responsibility initiatives, the corporation also expanded health camps and public awareness programmes to promote the rational use of medicines and improve public health practices.
As a major importer and supplier of pharmaceuticals, surgical consumables, laboratory chemicals and equipment, the SPC continues to play a key role in supporting institutions under the Ministry of Health, while overseeing the island-wide State Osusala pharmacy network to ensure public access to essential medicines.
The Ministry further stated that all medicines issued through the Osusala network undergo a rigorous four-stage quality testing process at the SPC’s state-of-the-art laboratories before being released to the market, ensuring high standards of safety and efficacy.
